This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

SO164

Depression and anxiety in a cohort of heart transplant recipients

DEPRESSION AND ANXIETY IN A COHORT OF HEART TRANSPLANTATION RECIPIENTS

Statistically significant reductions in HADS total, anxiety, and depression scores were observed 12 months after heart transplantation.

The aim was to assess depression and anxiety using the Hospital Anxiety and Depression Scale (HADS) in patients followed for one year after heart transplantation (HT). The study examined 37 adult patients enrolled in the heart transplantation program at Hospital Clinic in Barcelona between 2016 and 2023. During the waiting-list period, age, sex, disease duration, etiology of heart disease, Axis I diagnoses established using the Structured Clinical Interview for DSM-IV, HADS scores, and psychopharmacological treatment were assessed; HADS assessment was repeated one year after transplantation. The mean age of the sample was 53.65 ± 9.77 years; 26 patients were male (70.3%) and 11 were female (29.7%). The mean duration of heart disease was 11.11 ± 8.15 years, with ischemic cardiomyopathy present in 54.1% of patients and nonischemic cardiomyopathy in 21.6%. An Axis I psychiatric diagnosis was identified in 27% of the sample (10 patients), encompassing depressive, anxiety, sleep, and adjustment disorders; all patients with a diagnosis were receiving psychopharmacological treatment at the time of listing. The t-test showed statistically significant differences in all three HADS scores between the two assessments. During the waiting-list period, the mean HADS total score was 10.68 (standard deviation, SD = 5.51), the anxiety subscale score was 6.08 (SD = 3.5), and the depression subscale score was 4.59 (SD = 2.83); at the 12-month follow-up, the total score was 7.73 (SD = 5.28), the anxiety score was 4.84 (SD = 3.32), and the depression score was 2.89 (SD = 2.59). In conclusion, although HADS scores in the sample remained below the established cutoffs for screening for psychiatric morbidity (<12 for the total score and <8 for the subscales), a significant reduction in anxiety and depressive symptoms was observed 12 months after transplantation.

All WCP 2026 summaries